Identifying adults with congenital heart disease (CHD) at high risk for sudden death
for primary-prevention implantable cardioverter defibrillators (ICDs) remains a major
challenge. Inconsistencies among professional-society recommendations are a source
of confusion. This article summarizes and compares recommendations from the Canadian
Cardiovascular Society (CCS) (2009), Pediatric and Congenital Electrophysiology Society
(PACES) and Heart Rhythm Society (HRS) (2014), European Society of Cardiology (ESC)
sudden death guidelines (2015), European Heart Rhythm Association (EHRA), Association
for European Paediatric and Congenital Cardiology (AEPC), and ESC Working Group on
Grown-Up CHD (2018), and ESC guidelines on adult congenital heart disease (2020).
Major areas over which there is consensus are presented and scenarios with continued
clinical uncertainty, which offer important opportunities for future research are
highlighted.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Canadian Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD).Heart Rhythm. 2014; 11: e102-e165
- Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: executive summary.Can J Cardiol. 2010; 26: 143-150
- 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).Eur Heart J. 2015; 36: 2793-2867
- Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-Up Congenital Heart Disease, endorsed by HRS, PACES, APHRS, and SOLAECE.Europace. 2018; 20: 1719-1753
- 2020 ESC guidelines for the management of adult congenital heart disease.Eur Heart J. 2021; 42: 563-645
Article info
Publication history
Published online: September 30, 2021
Accepted:
September 24,
2021
Received:
July 26,
2021
Footnotes
See page 539 for disclosure information.
Identification
Copyright
© 2021 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.
